Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
A combination therapy that pairs low-dose amoxicillin (an antibiotic) with licorice and lotus root powder for the treatment of Helicobacter pylori infection. Amoxicillin is an aminopenicillin antibiotic that inhibits bacterial cell wall synthesis. Glycyrrhizin, the main active component in licorice, demonstrates antibacterial properties by inhibiting bacterial growth through targeting bacterial enzymes, affecting cell membrane formation, and altering membrane permeability. It also has anti-inflammatory and immunomodulatory effects. The combination approach may help reduce the required dose of amoxicillin while maintaining efficacy against H. pylori.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on licorice + lotus root powder + amoxicillin.